Log In Sign up
The largest database of trusted experimental protocols

Anti vista mih63

Manufactured by BioLegend
Visit Supplier

Anti-VISTA (MIH63) is a mouse monoclonal antibody that recognizes VISTA (V-domain Ig suppressor of T cell activation), a B7 family immune checkpoint protein. This antibody can be used for flow cytometry, immunofluorescence, and other applications.

Automatically generated - may contain errors

Lab products found in correlation

Anti cd69, by BioLegend (2 mentions) Anti tbet 4b10, by BioLegend (2 mentions) Anti cd5, by BioLegend (2 mentions) Anti cd28, by BioLegend (2 mentions)

2 protocols using anti vista mih63

1

Murine Immune Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies and reagents used for experiments include anti-CD11c (N418), anti-CD11b (M1/70), anti-CD8a (53–6.7), anti-B220 (RA3–6B2), anti-CD49B (DX5), anti-CD25 (PL61), Streptavidin (405232), anti-CD4 (GK1.5), anti-CD45.2 (104), anti-CD62L (Mel-14), Ly-6C (AL-21), anti-IFN-γ (XMG1.2), anti-CD3 (145–2C11), Rat IgG1 Isotype control (RTK2071), anti-CD28 (37.51), anti-CD5 (53–7.3), anti-VISTA (MIH63), anti-T-bet (4B10), (BioLegend), anti-CD69 (H1.2F3), anti-RORgt (q31–378), anti-TCR V beta 11 (RR3–15), anti-Nur77 (12.14), (BD), anti-TCR V alpha 3.2 (RR3–16), anti-Foxp3 (FJK-16 s), Fc-block (anti-CD16/32) (2.4G2), (ATCC).
Opejin A., Surnov A., Misulovin Z., Pherson M., Gross C., Iberg C.A., Fallahee I., Bourque J., Dorsett D, & Hawiger D. (2020). A Two-Step Process of Effector Programming Governs CD4+ T Cell Fate Determination Induced by Antigenic Activation in the Steady State. Cell reports, 33(8), 108424.
+ Open protocol
+ Expand
2

Murine Immune Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies and reagents used for experiments include anti-CD11c (N418), anti-CD11b (M1/70), anti-CD8a (53–6.7), anti-B220 (RA3–6B2), anti-CD49B (DX5), anti-CD25 (PL61), Streptavidin (405232), anti-CD4 (GK1.5), anti-CD45.2 (104), anti-CD62L (Mel-14), Ly-6C (AL-21), anti-IFN-γ (XMG1.2), anti-CD3 (145–2C11), Rat IgG1 Isotype control (RTK2071), anti-CD28 (37.51), anti-CD5 (53–7.3), anti-VISTA (MIH63), anti-T-bet (4B10), (BioLegend), anti-CD69 (H1.2F3), anti-RORgt (q31–378), anti-TCR V beta 11 (RR3–15), anti-Nur77 (12.14), (BD), anti-TCR V alpha 3.2 (RR3–16), anti-Foxp3 (FJK-16 s), Fc-block (anti-CD16/32) (2.4G2), (ATCC).
Opejin A., Surnov A., Misulovin Z., Pherson M., Gross C., Iberg C.A., Fallahee I., Bourque J., Dorsett D, & Hawiger D. (2020). A Two-Step Process of Effector Programming Governs CD4+ T Cell Fate Determination Induced by Antigenic Activation in the Steady State. Cell reports, 33(8), 108424.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!